Literature DB >> 11201031

Malignant vascular lesions of bone: radiologic and pathologic features.

D E Wenger1, L E Wold.   

Abstract

The malignant vascular tumors of bone represent an uncommon diverse group of tumors with widely variable clinical and radiographic presentations. Although the radiographic imaging features of the lytic osseous lesions typically seen with this group of tumors are relatively nonspecific, the propensity to develop multifocal disease in an anatomic region is a feature that can be helpful in suggesting the diagnosis of a vascular tumor. The differential diagnosis varies according to the age of the patient and presence of solitary or multifocal disease. The histologic features are variable and range from tumors with vasoformative features to those that mimic mesenchymal neoplasm or metastatic carcinoma. Familiarity with the radiographic and pathologic spectrum of disease is essential for making an accurate diagnosis in this diverse group of neoplasms. This paper will provide a review of the nomenclature for the malignant vascular tumors of bone and discuss the radiographic and pathologic differential diagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 11201031     DOI: 10.1007/s002560000261

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  39 in total

1.  Epithelioid and spindle cell haemangioma of bone.

Authors:  Fiona M Maclean; Julie Schatz; Stanley W McCarthy; Richard A Scolyer; Paul Stalley; S Fiona Bonar
Journal:  Skeletal Radiol       Date:  2006-05-11       Impact factor: 2.199

2.  Orthopaedic . radiology . pathology conference: left hip pain in a 62-year-old man.

Authors:  Fengdong Zhao; Zhijun Hu; Shunwu Fan
Journal:  Clin Orthop Relat Res       Date:  2008-09-09       Impact factor: 4.176

3.  Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions.

Authors:  Emanuela Palmerini; Robert G Maki; Eric L Staals; Marco Alberghini; Cristina R Antonescu; Crisitina Ferrari; Pietro Ruggieri; Andreas Mavrogenis; Franco Bertoni; Marilena Cesari; Anna Paioli; Emanuela Marchesi; Piero Picci; Stefano Ferrari
Journal:  Am J Clin Oncol       Date:  2014-12       Impact factor: 2.339

4.  Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity.

Authors:  Costantino Errani; Lei Zhang; David M Panicek; John H Healey; Cristina R Antonescu
Journal:  Clin Orthop Relat Res       Date:  2011-09-24       Impact factor: 4.176

5.  Multiple congenital cranial hemangiomas.

Authors:  George Koulouris; Padma Rao
Journal:  Skeletal Radiol       Date:  2005-02-19       Impact factor: 2.199

Review 6.  Epithelioid hemangioendothelioma of the spine: results at seven years of average follow-up in a series of 10 cases surgically treated and a review of literature.

Authors:  Alessandro Luzzati; Fabio Gagliano; Giuseppe Perrucchini; Gennaro Scotto; Carmine Zoccali
Journal:  Eur Spine J       Date:  2014-08-15       Impact factor: 3.134

Review 7.  A systematic approach to vertebral hemangioma.

Authors:  Simona Gaudino; Matia Martucci; Raffaella Colantonio; Emilio Lozupone; Emiliano Visconti; Antonio Leone; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2014-10-28       Impact factor: 2.199

8.  Multifocal epithelioid hemangioendothelioma of the phalanges of the hand.

Authors:  Melanie Bruegel; Simone Waldt; Gregor Weirich; Klaus Woertler; Ernst J Rummeny
Journal:  Skeletal Radiol       Date:  2005-08-13       Impact factor: 2.199

9.  Hemangioendothelioma with an epithelioid phenotype arising in hemangioma of the fibula.

Authors:  Zarine K Shah; Wilfred C G Peh; Tony W H Shek; Jimmy W K Wong; Eric P Chien
Journal:  Skeletal Radiol       Date:  2005-04-15       Impact factor: 2.199

Review 10.  Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features.

Authors:  Costantino Errani; Daniel Vanel; Marco Gambarotti; Marco Alberghini; Piero Picci; Cesare Faldini
Journal:  Skeletal Radiol       Date:  2012-09-21       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.